These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 10644785)

  • 21. The natural history of tardive dystonia. A long-term follow-up study of 107 cases.
    Kiriakakis V; Bhatia KP; Quinn NP; Marsden CD
    Brain; 1998 Nov; 121 ( Pt 11)():2053-66. PubMed ID: 9827766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tardive stereotypy and other movement disorders in tardive dyskinesias.
    Stacy M; Cardoso F; Jankovic J
    Neurology; 1993 May; 43(5):937-41. PubMed ID: 8492949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laryngeal tardive dyskinesia.
    Fève A; Angelard B; Lacau St Guily J
    J Neurol; 1995 Jul; 242(7):455-9. PubMed ID: 7595677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etiology, Diagnosis and Management of Oromandibular Dystonia: an Update for Stomatologists.
    Raoofi S; Khorshidi H; Najafi M
    J Dent (Shiraz); 2017 Jun; 18(2):73-81. PubMed ID: 28620630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oromandibular dystonia: long-term management with botulinum toxin.
    Sinclair CF; Gurey LE; Blitzer A
    Laryngoscope; 2013 Dec; 123(12):3078-83. PubMed ID: 24122897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.
    Kaufman DM
    J Neuropsychiatry Clin Neurosci; 1994; 6(1):50-3. PubMed ID: 8148637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open-label study of botulinum toxin A for treatment of tardive dystonia.
    Tarsy D; Kaufman D; Sethi KD; Rivner MH; Molho E; Factor S
    Clin Neuropharmacol; 1997 Feb; 20(1):90-3. PubMed ID: 9037579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oromandibular dystonia involving the lateral pterygoid muscles: four cases with different complexity.
    Møller E; Bakke M; Dalager T; Werdelin LM
    Mov Disord; 2007 Apr; 22(6):785-90. PubMed ID: 17290453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis.
    Dadgardoust PD; Rosales RL; Asuncion RM; Dressler D
    J Neural Transm (Vienna); 2019 Feb; 126(2):141-148. PubMed ID: 30604200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Torticollis spasmodicus as a manifestation of tardive dystonia].
    Silberbauer C; Rittmannsberger H
    Fortschr Neurol Psychiatr; 1995 Oct; 63(10):388-92. PubMed ID: 8529987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of 32 cases of tardive dystonia.
    Wojcik JD; Falk WE; Fink JS; Cole JO; Gelenberg AJ
    Am J Psychiatry; 1991 Aug; 148(8):1055-9. PubMed ID: 1677236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiological mechanisms of oromandibular dystonia.
    Manzo N; Ginatempo F; Belvisi D; Defazio G; Conte A; Deriu F; Berardelli A
    Clin Neurophysiol; 2022 Feb; 134():73-80. PubMed ID: 34979293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tongue protrusion dystonia: treatment with botulinum toxin.
    Charles PD; Davis TL; Shannon KM; Hook MA; Warner JS
    South Med J; 1997 May; 90(5):522-5. PubMed ID: 9160072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Botulinum toxin treatment of patients with oromandibular dystonia].
    Erdal J; Werdelin LM; Prytz S; Fuglsang-Frederiksen A; Møller E
    Ugeskr Laeger; 2000 Nov; 162(48):6567-71. PubMed ID: 11187229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nosology of tardive syndromes.
    Frei K; Truong DD; Fahn S; Jankovic J; Hauser RA
    J Neurol Sci; 2018 Jun; 389():10-16. PubMed ID: 29433810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tardive dyskinesia presenting as gastrointestinal disorder.
    Goldberg RJ; Morris PL; Lidofsky S
    J Clin Psychiatry; 1990 Jun; 51(6):253-4. PubMed ID: 1971823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics: a cross-sectional and retrospective study.
    Ryu S; Yoo JH; Kim JH; Choi JS; Baek JH; Ha K; Kwon JS; Hong KS
    J Clin Psychopharmacol; 2015 Feb; 35(1):13-21. PubMed ID: 25485636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients.
    Chouksey A; Pandey S
    Tremor Other Hyperkinet Mov (N Y); 2020 Oct; 10():48. PubMed ID: 33178486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical aspects of tardive dyskinesias induced by neuroleptics].
    Villeneuve A; Lajeunesse C
    Encephale; 1988 Sep; 14 Spec No():209-14. PubMed ID: 2905648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemodenervation for Oromandibular Dystonia Utilizing Botulinum Toxins.
    Ameer MA; Bhatti D
    Cureus; 2021 Oct; 13(10):e18425. PubMed ID: 34692256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.